NO20081368L - Derivater av 2-amintiazoler og 2-aminooksazoler, fremgangsmate for fremstilling derav samt deres anvendelse som farmasoytika - Google Patents

Derivater av 2-amintiazoler og 2-aminooksazoler, fremgangsmate for fremstilling derav samt deres anvendelse som farmasoytika

Info

Publication number: NO20081368L
Authority: NO; Norway
Prior art keywords: disorders; aminoozazoles; aminothiazoles; derivatives; processes
Prior art date: 2005-09-29

Application number

NO20081368A

Other languages

English (en)

Norwegian (no)

Inventor

Stefanie Keil

Matthias Urmann

Wolfgang Wendler

Maike Glien

Karen Chandross

Lan Lee

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-29

Filing date

2008-03-14

Publication date

2008-06-18

2008-03-14 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2008-06-18 Publication of NO20081368L publication Critical patent/NO20081368L/no

Links

RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical class NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
150000001875 compounds Chemical class 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
206010022489 Insulin Resistance Diseases 0.000 abstract 1
239000000556 agonist Substances 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
230000003210 demyelinating effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000004129 fatty acid metabolism Effects 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
208000015122 neurodegenerative disease Diseases 0.000 abstract 1
210000001428 peripheral nervous system Anatomy 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Obesity (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20081368A 2005-09-29 2008-03-14 Derivater av 2-amintiazoler og 2-aminooksazoler, fremgangsmate for fremstilling derav samt deres anvendelse som farmasoytika NO20081368L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP05021279		2005-09-29
PCT/EP2006/009302 WO2007039176A1 (fr)	2005-09-29	2006-09-26	Derives de 2 -aminthiazoles et 2-aminooxazoles : procedes de preparation et utilisation comme produits pharmaceutiques

Publications (1)

Publication Number	Publication Date
NO20081368L true NO20081368L (no)	2008-06-18

Family

ID=35764446

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20081368A NO20081368L (no)	2005-09-29	2008-03-14	Derivater av 2-amintiazoler og 2-aminooksazoler, fremgangsmate for fremstilling derav samt deres anvendelse som farmasoytika

Country Status (20)

Country	Link
US (1)	US7655679B2 (fr)
EP (1)	EP1931659B1 (fr)
JP (1)	JP2009509987A (fr)
KR (1)	KR20080048510A (fr)
CN (1)	CN101277953A (fr)
AR (1)	AR056542A1 (fr)
AT (1)	ATE480536T1 (fr)
AU (1)	AU2006299090A1 (fr)
BR (1)	BRPI0616477A2 (fr)
CA (1)	CA2624100A1 (fr)
DE (1)	DE602006016830D1 (fr)
IL (1)	IL190230A0 (fr)
MA (1)	MA29806B1 (fr)
MY (1)	MY148883A (fr)
NO (1)	NO20081368L (fr)
NZ (1)	NZ566876A (fr)
RU (1)	RU2008112199A (fr)
TW (1)	TW200732328A (fr)
UY (1)	UY29832A1 (fr)
WO (1)	WO2007039176A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0820400A2 (pt)	2007-11-20	2015-05-19	Sumitomo Chemical Co	Composto de piridina, composição pesticida e método de controle de pragas.
US9073881B2 (en)	2011-09-23	2015-07-07	Hoffmann-La Roche Inc.	Benzoic acid derivatives
WO2013066839A2 (fr) *	2011-10-31	2013-05-10	Glaxosmithkline Llc	Composés et procédés
MX2021014410A (es)	2019-05-31	2022-03-17	Avolynt	Composiciones y métodos para tratar la enfermedad metabólica.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5641796A (en)	1994-11-01	1997-06-24	Eli Lilly And Company	Oral hypoglycemic agents
GB9919413D0 (en)	1999-08-18	1999-10-20	Zeneca Ltd	Chemical compounds
EP1480957A1 (fr) *	2002-03-01	2004-12-01	Smithkline Beecham Corporation	Activateurs de hppars
US6653334B1 (en)	2002-12-27	2003-11-25	Kowa Co., Ltd.	Benzoxazole compound and pharmaceutical composition containing the same
DE602004004631D1 (de)	2004-04-01	2007-03-22	Sanofi Aventis Deutschland	Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika

2006
- 2006-09-26 AT AT06792250T patent/ATE480536T1/de not_active IP Right Cessation
- 2006-09-26 CA CA002624100A patent/CA2624100A1/fr not_active Abandoned
- 2006-09-26 NZ NZ566876A patent/NZ566876A/en not_active IP Right Cessation
- 2006-09-26 RU RU2008112199/04A patent/RU2008112199A/ru not_active Application Discontinuation
- 2006-09-26 AU AU2006299090A patent/AU2006299090A1/en not_active Abandoned
- 2006-09-26 BR BRPI0616477-3A patent/BRPI0616477A2/pt not_active IP Right Cessation
- 2006-09-26 KR KR1020087007472A patent/KR20080048510A/ko not_active Withdrawn
- 2006-09-26 WO PCT/EP2006/009302 patent/WO2007039176A1/fr not_active Ceased
- 2006-09-26 DE DE602006016830T patent/DE602006016830D1/de active Active
- 2006-09-26 CN CNA2006800360458A patent/CN101277953A/zh active Pending
- 2006-09-26 EP EP06792250A patent/EP1931659B1/fr active Active
- 2006-09-26 JP JP2008532646A patent/JP2009509987A/ja not_active Abandoned
- 2006-09-27 MY MYPI20064226A patent/MY148883A/en unknown
- 2006-09-27 TW TW095135659A patent/TW200732328A/zh unknown
- 2006-09-27 AR ARP060104224A patent/AR056542A1/es not_active Application Discontinuation
- 2006-09-29 UY UY29832A patent/UY29832A1/es not_active Application Discontinuation
2008
- 2008-03-14 NO NO20081368A patent/NO20081368L/no not_active Application Discontinuation
- 2008-03-17 IL IL190230A patent/IL190230A0/en unknown
- 2008-03-24 MA MA30782A patent/MA29806B1/fr unknown
- 2008-03-26 US US12/055,771 patent/US7655679B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20080227834A1 (en)	2008-09-18
CA2624100A1 (fr)	2007-04-12
CN101277953A (zh)	2008-10-01
TW200732328A (en)	2007-09-01
NZ566876A (en)	2010-05-28
JP2009509987A (ja)	2009-03-12
AU2006299090A1 (en)	2007-04-12
AR056542A1 (es)	2007-10-10
MA29806B1 (fr)	2008-09-01
WO2007039176A1 (fr)	2007-04-12
EP1931659B1 (fr)	2010-09-08
UY29832A1 (es)	2007-04-30
KR20080048510A (ko)	2008-06-02
MY148883A (en)	2013-06-14
US7655679B2 (en)	2010-02-02
ATE480536T1 (de)	2010-09-15
IL190230A0 (en)	2008-11-03
EP1931659A1 (fr)	2008-06-18
BRPI0616477A2 (pt)	2011-06-21
DE602006016830D1 (de)	2010-10-21
RU2008112199A (ru)	2009-10-10

Similar Documents

Publication	Publication Date	Title
NO20081370L (no)	2008-06-17	Fenyl-[1,2,4]-okadiazol-5-on-derivater med fenylgruppe, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytika
NO20081369L (no)	2008-05-28	Fenyl- og pyridinyl-1,2,4-oksadiazolonderivater, fremgangsmate for deres fremstilling og deres anvendelse som farmasoytika
NO20092293L (no)	2009-09-08	Sulfonyl-fenyl-2H-[1,2,4]oksodiazol-5-onderivater, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytiske midler
NO20081682L (no)	2008-05-06	4-oksy-N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for deres fremstilling og deres anvendelse som farmasoytika
NO20064201L (no)	2006-12-13	Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
WO2010046445A3 (fr)	2010-07-01	Dérivées d’urée de nortropanes substitués, médicaments contenant de tels composés et leur utilisation
NO20081681L (no)	2008-04-29	N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
HRP20130406T1 (hr)	2013-06-30	Medikamenti s aktivnošä†u prema receptoru hm74a
TW200505880A (en)	2005-02-16	Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
NO20073719L (no)	2007-08-22	Kjemiske forbindelser
TW200615266A (en)	2006-05-16	Organic compounds
NO20082643L (no)	2008-09-01	Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
MX2010006647A (es)	2010-08-17	Piridil-n-[1,3,4]-tiadiazol-2-il-bencenosulfonamidas ciclicas, procedimientos para su preparacion y su uso como productos farmaceuticos.
WO2009098715A3 (fr)	2009-10-15	Nouveaux dérivés de pyrazolo [3, 4 -d] pyrimidine en tant qu’agents anticancéreux
WO2010095768A8 (fr)	2011-08-04	Composés de 4–isopropylphényl glucitol comme inhibiteurs de sglt1
MX2007002689A (es)	2007-05-16	7-azaindoles y su uso como agonistas de ppar.
NO20064981L (no)	2006-12-28	Oksadiazolonderivater som PPAR delta agonister
TW200508210A (en)	2005-03-01	Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
NO20081368L (no)	2008-06-18	Derivater av 2-amintiazoler og 2-aminooksazoler, fremgangsmate for fremstilling derav samt deres anvendelse som farmasoytika
NO20081676L (no)	2008-04-29	Bicykliske aryl-sulfonylsyre[1,3,4]-tiadlazol-2-yl-amlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
NO20064951L (no)	2006-10-30	1,3,4-oksadiazol-2-oner som PPAR delta-modulatorer og deres anvendelse
NO20084177L (no)	2008-11-12	Substituerte Imidazo[2,1-B]thiazolforbindelser og deres anvendelse for produksjon av legemidler
NO20081675L (no)	2008-04-23	Cykliske N-[1,3,4]-tiadiazol-2-yl-benzensulfonamlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
TW200621732A (en)	2006-07-01	Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
TW200510399A (en)	2005-03-16	1, 3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals

Legal Events

Date	Code	Title	Description
2012-04-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application